All comparisons
GILD vs MRNA
Gilead Sciences, Inc. vs Moderna, Inc.
Overview
GILDGilead Sciences, Inc.
Score APrice
$145.65
Fair Value
$172.32
Upside
+18.3%
Convex Score
9/10
MRNAModerna, Inc.
Score D (Speculative)Price
$135.61
Fair Value
$69.30
Upside
-48.9%
Convex Score
1/10
Valuation
GILD
Bear$131.09
Base$238.12
Bull$331.82
Fair Value$172.32
MRNA
Bear$41.58
Base$69.30
Bull$97.02
Fair Value$69.30
Quality
GILD
Grade
C
Score
72/100
Classification
Blue Chip
Rating
Score A
MRNA
Grade
D
Score
42/100
Classification
Compounder
Rating
Score D (Speculative)
Company Info
| GILD | MRNA | |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Biotechnology |
| Classification | Blue Chip | Compounder |
Verdict
GILD has better risk/reward
GILD: Higher upside potentialGILD: Higher Convex ScoreGILD: Better quality grade